User profiles for P. Aukrust

Pål Aukrust

Professor of Medicine
Verified email at ous-hf.no
Cited by 5620

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the …

…, E Hirsch, SD Anker, P Aukrust… - European journal of …, 2009 - Wiley Online Library
The increasing prevalence of heart failure poses enormous challenges for health care systems
worldwide. Despite effective medical interventions that target neurohumoral activation, …

Inflammatory cytokines in heart failure: mediators and markers

…, T Ueland, LE Vinge, A Finsen, A Yndestad, P Aukrust - Cardiology, 2012 - karger.com
… L, Ueland T, Fjeld J, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus
J, Andreassen AK, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P: …

Systemic inflammation in heart failure–the whys and wherefores

…, E Øie, T Ueland, L Gullestad, P Aukrust - Heart failure …, 2006 - Springer
Patients with chronic heart failure (HF) are characterized by systemic inflammation, as
evident by raised circulating levels of several inflammatory cytokines with increasing levels …

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

…, PA Torjesen, K Birkeland, K Bjøro, P Aukrust - Journal of …, 2006 - Elsevier
… Comparing NASH with simple steatosis, levels of TNF-α (P=0.024) and CCL2/MCP-1 (P=0.012)
were elevated and adiponectin (in women) (P=0.001) were decreased also after …

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

P Aukrust, T Ueland, E Lien, K Bendtzen… - The American journal of …, 1999 - Elsevier
… 2-tailed p values and values <0.05 were considered significant. However, particular attention
should be directed toward smaller p values <0.01, because a considerable number of p

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

…, SS Frøland, K Krohg-Sørensen, D Russell, P Aukrust… - Circulation, 2007 - Am Heart Assoc
Background— Although the participation of inflammation in atherogenesis is widely recognized,
the identification of the different components has not been clarified. In particular, the role …

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

…, B Halvorsen, TH Karlsen, P Aukrust… - Journal of internal …, 2015 - Wiley Online Library
… Plasma levels of TMAO (P = 0.01), choline (P < 0.001) and betaine (P < 0.001) were … P
< 0.05, **P < 0.01, ***P < 0.001 versus healthy control subjects matched for age and sex; †P

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the …

P Aukrust, F Müller, T Ueland, T Berget, E Aaser… - Circulation, 1999 - Am Heart Assoc
… Pål AukrustP<0.05 (2-sided) was considered significant. … P<0.05 versus controls, #P<0.05
versus patients with stable angina. Data are given as medians and ranges. …

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

…, B Halvorsen, F Müller, P Aukrust… - Proceedings of the …, 2020 - National Acad Sciences
… without respiratory failure (P = 0.008 and P = 0.034). Logistic regression showed increasing
odds of respiratory failure with sC5b-9 (odds ratio 31.9, 95% CI 1.4 to 746, P = 0.03) and …

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

…, E Lien, G Valen, T Espevik, P Aukrust… - Cardiovascular …, 2013 - academic.oup.com
Aims Nucleotide-binding oligomerization domain-Like Receptor with a Pyrin domain 3 (NLRP3)
is considered necessary for initiating a profound sterile inflammatory response. NLRP3 …